Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-09-26

FDA Approved: LEVETIRACETAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for a generic levetiracetam product from Lupin Pharmaceuticals, Inc. (ANDA 078154).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)